• International sales director based in Belgium

• No presence in France

• Submission for a PECT with an international study (w/o French sites) published in 2015

• PECT approved in November 2021

Main achievements

–Opening of 5 reference centers with a dozen of implantations

–3 presentations + 1 live in the box during annual academic meetings

–Scouting a clinical sales manager (hired in Feb 22)

–Weekly review of the account planning, pipeline and forecast

–Plan of staff and referral meetings

–Identification of 2 early users as a proctor/speaker

Next steps

–Extension of the headcount

–Signature and implementation of the proctor/speaker contract

–Disease awareness marketing campaign endorsed by the local academic society (SFC)

–Setup a registry endorsed by the local academic society (SFC)

–Enrollement of 2 reference centers in an international randomized control trial

• Presence in France with its own commercial organisation focused on delivering the revenues with core products
• Brand new technology changing the management of a disease in acute phase aiming at reimbursement
• Limited clinical data
• Operational leadership by the the Global Marketing team based in the USA
  => Approaching key potential users among reference centers
  => Identifying a pathway for a temporary procedure code requested by the community of physicians
  =>Triggering single-center studies
  => Building-up a community of early users among Europe